InvestorsHub Logo
Followers 1
Posts 122
Boards Moderated 0
Alias Born 07/10/2013

Re: MinnieM post# 54201

Thursday, 02/13/2014 8:57:37 AM

Thursday, February 13, 2014 8:57:37 AM

Post# of 403102

Kevetrin is in a trial at Harvard's Dana Farber in large part due to Dr Menon's connections there.



Thanks, Karin. The reason that most people gained confidence to risk money in the shares of CTIX is the fact that they have a clinical trial going on at DF. However the company is entirely in the control of 2 individuals who are still able to reward themselves lavishly from the company's assets, as evident from having given themselves a very significant portion of the company after having sold it to the public by going public.

The unsolved mystery is, even if Kevetrin is to hit the jackpot, what will the non-management shareholders be left with? To have confidence on that question, the current unaccountable, mutually rewarding, 2-person management must have demonstrated integrity.

It really matters if the 60+M shares owned by the public is something like 50% of the company or will end up being 10% of the company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News